Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
Mayo Clinic
Mayo Clinic
Fusion Pharmaceuticals Inc.
TriSalus Life Sciences, Inc.
Turnstone Biologics, Corp.
Foghorn Therapeutics Inc.
Novartis
Polaris Group
Yale University
University of Southern California